Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Genomic Solutions (AGS) is a specialized health technology company focused on pharmacogenomics and nutrigenomics testing. The company provides individuals and healthcare practitioners with actionable genetic data to personalize medication selection, dosage, and nutritional plans. AGS's core offerings include DNA-based reports that identify how a patient's genetic makeup affects their response to over 400 common medications and various dietary components. By leveraging these insights, the company aims to reduce the incidence of adverse drug reactions and improve long-term health outcomes through data-driven lifestyle modifications. Headquartered in Hong Kong with operations in the United States, AGS partners with clinics and corporations to integrate genomic science into standard wellness and medical care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Genomic Solutions.